Verona Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 25 shareholders own 75.3% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.8%	RA Capital Management, L.P.	6,317,990	US$97.6m	0%	1.36%
6.31%	New Enterprise Associates, Inc.	5,108,563	US$78.9m	0%	4.23%
6.05%	FMR LLC	4,902,377	US$75.7m	-29.5%	0.01%
4.77%	Perceptive Advisors LLC	3,866,214	US$59.7m	-3.52%	1.41%
4.67%	Wellington Management Group LLP	3,783,994	US$58.5m	-15.3%	0.01%
4.66%	OrbiMed Advisors LLC	3,777,778	US$58.4m	0%	0.83%
4.46%	Vivo Capital, LLC	3,610,177	US$55.8m	-15.1%	4.56%
3.94%	Deep Track Capital, LP	3,187,415	US$49.2m	0%	1.69%
3.72%	Frazier Life Sciences Management, LP	3,014,349	US$46.6m	0%	2.14%
3.08%	Federated Hermes, Inc.	2,493,530	US$38.5m	0%	0.1%
3.03%	Abingworth LLP	2,457,500	US$38.0m	0%	11.69%
2.93%	Octagon Capital Advisors LP	2,369,000	US$36.6m	0%	6.45%
2.23%	Janus Henderson Group plc	1,803,361	US$27.9m	10.2%	0.01%
2.05%	Maverick Capital, Ltd.	1,656,492	US$25.6m	0%	0.46%
1.96%	Jennison Associates LLC	1,585,385	US$24.5m	9.9%	0.02%
1.96%	David Zaccardelli	1,583,449	US$24.5m	7.65%	no data
1.81%	Mark Hahn	1,469,572	US$22.7m	8.29%	no data
1.7%	Eventide Asset Management, LLC	1,377,781	US$21.3m	62.1%	0.36%
1.49%	First Turn Management, LLC	1,206,291	US$18.6m	0%	3.15%
1.38%	Aisling Capital Management LP	1,115,352	US$17.2m	0%	7.14%
1.29%	Norges Bank Investment Management	1,047,817	US$16.2m	0%	no data
1.17%	Hood River Capital Management LLC	946,602	US$14.6m	0%	0.38%
1.04%	Bellevue Asset Management AG	839,996	US$13.0m	-1.91%	0.15%
0.96%	Avidity Partners Management, L.P.	780,900	US$12.1m	-5.95%	0.47%
0.83%	Rice Hall James & Associates, LLC	675,757	US$10.4m	44.1%	0.63%